About
Gliclazide is an oral hypoglycemic agent belonging to the sulfonylurea class, primarily used in the management of type 2 diabetes mellitus. It works by stimulating the beta cells of the pancreas to release insulin, thereby lowering blood glucose levels. Gliclazide also possesses some extrapancreatic effects, including improving insulin sensitivity in peripheral tissues and reducing hepatic glucose production, though its primary mechanism is insulin secretion. This medication is an important tool in achieving and maintaining glycemic targets, which is crucial for preventing or delaying the onset of long-term microvascular and macrovascular complications associated with diabetes, such as neuropathy, nephropathy, retinopathy, and cardiovascular disease. It is typically prescribed when diet and exercise alone are insufficient to achieve adequate glycemic control. Regular monitoring of blood glucose is essential to optimize treatment and prevent hypoglycemia, which is a common side effect of sulfonylureas and requires careful management.
Uses
- Management of Type 2 Diabetes Mellitus.
- To lower high blood sugar levels.
- Used when diet and exercise are insufficient.
- As part of a comprehensive diabetes management plan.
Directions For Use
Take this medication orally, usually once or twice daily with breakfast or the first main meal. Swallow the tablet whole; do not crush, chew, or break it.
Benefits
- Effective in lowering blood glucose levels.
- Helps achieve better glycemic control.
- Flexible dosing options.
- Reduces risk of long-term diabetes complications.
- Improves insulin secretion from the pancreas.
- Can be used alone or in combination therapy.
Side Effects
- Hypoglycemia (low blood sugar)
- Nausea
- Diarrhea
- Abdominal pain
- Headache
- Dizziness
- Skin rash
- Itching
- Weight gain
- Constipation
- Indigestion
- Allergic reactions
Safety Measures
- Alcohol - Alcohol can increase the risk of hypoglycemia when taken with this medication. It should be consumed in moderation or avoided.
- Pregnancy - Generally not recommended during pregnancy. Consult a doctor as insulin therapy is often preferred for glycemic control in pregnant women.
- Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and cause hypoglycemia in the infant.
- Liver - Use with caution in patients with liver impairment, as it may increase the risk of hypoglycemia and drug accumulation. Dose adjustment may be necessary.
- Kidney - Use with caution in patients with kidney impairment, as it may lead to drug accumulation and increased risk of hypoglycemia. Dose adjustment may be required.
- Lung - No specific contraindications or major safety concerns directly related to lung conditions are typically associated with this medication.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!